Noul Co., Ltd. is a Yongin, South Korea diagnostics company using AI-driven digital microscopy for blood and tissue tests.
Founded in 2015 in Yongin, South Korea, Noul Co., Ltd. develops diagnostic solutions focused on blood and tissue diagnostics. Its miLab Solution combines digital microscopy with artificial intelligence for malaria and cancer detection, with miLab MAL and miLab BCM serving labs and healthcare providers in Europe, the Middle East and Africa. David Lim is CEO, and Youngmin Shin is a co-founder. Noul's IPO on March 3, 2022 raised KRW 15 billion by selling 1.5 million shares at KRW 10,000 each.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in